Warning and Advisories for Healthcare Providers > Letters to Healthcare Providers

Letters to Healthcare Providers   Direct-acting antivirals for chronic hepatitis C: risk of hypoglycaemia in patients with diabetes (Letter to Healthcare Professionals)       Attachment: Direct-acting antivirals for chronic hepatitis C: risk of hypoglycaemia in patients with diabetes   Related Information: Direct-acting antivirals - Assessing the potential risk of abnormal blood sugar ... Posted 2020-02-18 Canada: Summary Safety Review - Direct-acting antivirals - Assessing the potenti... Posted 2020-02-18 The United Kingdom: Direct-acting antivirals for chronic hepatitis C: risk of hy... Posted 2018-12-19